Cytokinetics Stock Buy Hold or Sell Recommendation

CYTK
 Stock
  

USD 43.90  2.90  7.07%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Cytokinetics is 'Hold'. Macroaxis provides Cytokinetics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CYTK positions. The advice algorithm takes into account all of Cytokinetics' available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Cytokinetics' buy-and-hold perspective. Continue to Cytokinetics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Cytokinetics and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Cytokinetics.

Execute Cytokinetics Buy or Sell Advice

The Cytokinetics recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cytokinetics. Macroaxis does not own or have any residual interests in Cytokinetics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cytokinetics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell CytokineticsBuy Cytokinetics
Hold

Volatility

Very steadyDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Very HighDetails

Economic Sensitivity

Responds to the marketDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Cytokinetics has a Risk Adjusted Performance of 0.1223, Jensen Alpha of 0.6333, Total Risk Alpha of 1.08, Sortino Ratio of 0.104 and Treynor Ratio of 0.3239
Cytokinetics advice module can be used to check and cross-verify current investment recommendation provided by analysts analyzing the company's potential to grow using all of fundamental, technical, data market data available at the time. To make sure Cytokinetics is not overpriced, please confirm all Cytokinetics fundamentals, including its gross profit, short ratio, current liabilities, as well as the relationship between the total debt and market capitalization . Given that Cytokinetics has a price to earning of (37.76) X, we suggest you to validate Cytokinetics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Cytokinetics Trading Alerts and Improvement Suggestions

Cytokinetics has very high historical volatility over the last 90 days
Cytokinetics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 70.43 M. Net Loss for the year was (215.31 M) with loss before overhead, payroll, taxes, and interest of (89.51 M).
Cytokinetics currently holds about 471.64 M in cash with (142.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.56.
Cytokinetics has a poor financial position based on the latest SEC disclosures
Latest headline from www.bdtonline.com: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 - Bluefield Daily Telegraph

Cytokinetics current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cytokinetics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cytokinetics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price58.83
Target Median Price57.50
Target High Price75.00
Recommendation Mean1.80
Number Of Analyst Opinions12
Target Low Price46.00
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Cytokinetics Returns Distribution Density

The distribution of Cytokinetics' historical returns is an attempt to chart the future uncertainty of Cytokinetics' future price movements. The chart of the probability distribution of Cytokinetics stock daily returns describes the distribution of returns around its average expected value. We use Cytokinetics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cytokinetics returns is essential to provide solid investment advice for Cytokinetics stock.
Mean Return0.41Value At Risk-8.11
Potential Upside8.35Standard Deviation5.00
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cytokinetics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Cytokinetics Cash Flow Accounts

201720182019202020212022 (projected)
Capital Expenditure(2.88 M)(875 K)(2.62 M)(11.05 M)(48.87 M)(50.16 M)
Depreciation Amortization and Accretion1.92 M1.24 M1.29 M1.83 M2.28 M1.87 M
Net Cash Flow or Change in Cash and Cash Equivalents58.33 M(82.95 M)(5.82 M)46.55 M29.68 M32.02 M
Issuance Purchase of Equity Shares134.04 M3.23 M37.61 M231.97 M319.98 M345.24 M
Issuance Repayment of Debt Securities15 M1.26 M9.9 M122.18 M140.51 M151.6 M
Net Cash Flow from Financing225.92 M13.13 M159.79 M234.12 M319.98 M345.24 M
Net Cash Flow from Investing(65.83 M)5.13 M(74.71 M)(196.51 M)(147.78 M)(151.67 M)
Net Cash Flow Investment Acquisitions and Disposals(62.95 M)6.01 M(72.09 M)(185.46 M)(98.91 M)(101.51 M)
Net Cash Flow from Operations(101.76 M)(101.22 M)(90.91 M)8.94 M(142.52 M)(146.27 M)
Share Based Compensation9.03 M9.76 M10.76 M17.62 M26.83 M28.95 M

Cytokinetics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cytokinetics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cytokinetics stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cytokinetics stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
0.63
β
Beta against DOW1.22
σ
Overall volatility
5.11
Ir
Information ratio 0.12

Cytokinetics Volatility Alert

Cytokinetics exhibits above-average semi-deviation for your current time horizon. We encourage investors to investigate Cytokinetics individually to make sure intended market timing strategies and available technical indicagtors are consistent with their estimates about Cytokinetics future systematic risk. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cytokinetics' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cytokinetics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Cytokinetics Implied Volatility

Cytokinetics' implied volatility exposes the market's sentiment of Cytokinetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cytokinetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cytokinetics stock will not fluctuate a lot when Cytokinetics' options are near their expiration.

Cytokinetics Fundamentals Vs Peers

Comparing Cytokinetics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cytokinetics' direct or indirect competition across all of the common fundamentals between Cytokinetics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cytokinetics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cytokinetics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Cytokinetics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Cytokinetics to competition
FundamentalsCytokineticsPeer Average
Return On Equity(120.54) %(0.31) %
Return On Asset(16.94) %(0.14) %
Operating Margin(264.54) %(5.51) %
Current Valuation3.18 B16.62 B
Shares Outstanding84.39 M571.82 M
Shares Owned by Insiders4.87 %10.09 %
Shares Owned by Institutions114.14 %39.21 %
Number of Shares Shorted8.01 M4.71 M
Price to Earning(37.76) X28.72 X
Price to Book13.22 X9.51 X
Price to Sales47.08 X11.42 X
Revenue70.43 M9.43 B
Gross Profit(89.51 M)27.38 B
EBITDA(184.04 M)3.9 B
Net Income(215.31 M)570.98 M
Cash and Equivalents471.64 M2.7 B
Cash per Share5.56 X5.01 X
Total Debt269.93 M5.32 B
Debt to Equity1.11 %48.70 %
Current Ratio7.45 X2.16 X
Book Value Per Share2.97 X1.93 K
Cash Flow from Operations(142.52 M)971.22 M
Short Ratio9.05 X4.00 X
Earnings Per Share(3.11) X3.12 X
Price to Earnings To Growth(0.56) X4.89 X
Number of Employees25318.84 K
Beta1.36-0.15
Market Capitalization3.32 B19.03 B
Total Asset115.24 M29.47 B
Retained Earnings(887.78 M)9.33 B
Working Capital81.46 M1.48 B
Current Asset113.11 M9.34 B
Current Liabilities31.65 M7.9 B
   Exercise or conversion by Fady Malik of 21500 shares of Cytokinetics subject to Rule 16b-3 [view details]

About Cytokinetics Buy or Sell Advice

When is the right time to buy or sell Cytokinetics? Buying financial instruments such as Cytokinetics Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Cytokinetics investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Accounts Payable8.16 M8.05 M21.09 M22.75 M
Receivables5.16 M4.42 M51.82 M55.91 M

Use Investing Ideas to Build Portfolios

In addition to having Cytokinetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Manufacturing Thematic Idea Now

Manufacturing
Manufacturing Theme
Companies that provide goods across residential, commercial and industrial construction such as machinery, tools, or lumber production. The Manufacturing theme has 20 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Manufacturing Theme or any other thematic opportunities.
View All  Next Launch Manufacturing
Continue to Cytokinetics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Cytokinetics information on this page should be used as a complementary analysis to other Cytokinetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Cytokinetics Stock analysis

When running Cytokinetics price analysis, check to measure Cytokinetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytokinetics is operating at the current time. Most of Cytokinetics' value examination focuses on studying past and present price action to predict the probability of Cytokinetics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cytokinetics' price. Additionally, you may evaluate how the addition of Cytokinetics to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Cytokinetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytokinetics. If investors know Cytokinetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytokinetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
3.5 B
Quarterly Revenue Growth YOY
-0.82
Return On Assets
-0.19
Return On Equity
-2.8
The market value of Cytokinetics is measured differently than its book value, which is the value of Cytokinetics that is recorded on the company's balance sheet. Investors also form their own opinion of Cytokinetics' value that differs from its market value or its book value, called intrinsic value, which is Cytokinetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytokinetics' market value can be influenced by many factors that don't directly affect Cytokinetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytokinetics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cytokinetics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytokinetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.